Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
Just nowQuarterly Activities Report - March 2026
7m agoAppendix 4C and Quarterly Activities Report - March 2026
33m agoDiagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
34m agoING completes share buyback and announces new programme of up to €1.0 billion
34m agoargenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc

About

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 23 2026
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026
Feb 25 2026
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook
Feb 18 2026
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call
Jan 2 2026
Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance
Nov 10 2025
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance

Financials

Revenue
$296.15 M
Market Cap
$577.23 M
P/E Ratio
23.60
EPS
0.15

Community Chat

Ask AI

6ix6ix